24 – Liver Transplantation for Metabolic Disease

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-7216-0118-2.50029-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of the Cystic Fibrosis Gene : Chromosome Walking and Jumping Author ( s ) :

  2008cited by this paper
• Plain radiographic, nuclear medicine and angiographic observations of hepatogenic pulmonary angiodysplasia

  2005cited by this paper
• Liver transplantation for tyrosinemia

  2005cited by this paper
• Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship

  2004cited by this paper
• Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation

  2004cited by this paper
• Progress in treatment and outcome for children with neonatal haemochromatosis

  2003cited by this paper
• Prometheus's vulture and the stem-cell promise.

  2003cited by this paper
• Nuclear transplantation, embryonic stem cells and the potential for cell therapy.

  2003cited by this paper
• Incidence of Renal and Liver Rejection and Patient Survival Rate Following Combined Liver and Kidney Transplantation

  2003cited by this paper
• Hepatic copper metabolism: Insights from genetic disease

  2003cited by this paper
• Liver and intestinal transplantation in a child with cystic fibrosis: A case report

  2003cited by this paper
• Liver transplantation for Wilson’s disease: long-term results and quality-of-life assessment

  2003cited by this paper
• Primary hyperoxaluria: Simultaneous combined liver and kidney transplantation from a living related donor

  2003cited by this paper
• Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population

  2003cited by this paper
• Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.

  2003cited by this paper
• Reversal of oxalosis cardiomyopathy after combined liver and kidney transplantation

  2002cited by this paper
• Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy.

  2002cited by this paper
• An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.

  2002cited by this paper
• Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver

  2002cited by this paper
• Hepatic copper concentration in children undergoing living related liver transplantation due to Wilsonian fulminant hepatic failure

  2002cited by this paper
• Transplantation for cystic fibrosis: Outcome following early liver transplantation

  2002cited by this paper
• Glycogen storage disease type I: pathophysiology of liver adenomas

  2002cited by this paper
• Long‐term survival after liver transplantation in children with metabolic disorders

  2002cited by this paper
• The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.

  2002cited by this paper
• New Insights Into the Interactions Between T-Cell Costimulatory Blockade and Conventional Immunosuppressive Drugs

  2002cited by this paper
• Diagnosis and treatment of maple syrup disease: a study of 36 patients.

  2002cited by this paper
• Diagnosis and treatment of Wilson's disease

  2002cited by this paper
• Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.

  2002cited by this paper
• Renal allograft survival in patients with oxalosis.

  2002cited by this paper
• Metabolic stroke in methylmalonic acidemia five years after liver transplantation.

  2002cited by this paper
• Liver transplantation in metabolic diseases: Current status

  2002cited by this paper
• Prenatal screening for cystic fibrosis: where are we now?

  2002cited by this paper
• Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.

  2001cited by this paper
• Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children.

  2001cited by this paper
• Alternative pathway therapy for urea cycle disorders: twenty years later.

  2001cited by this paper
• LIVING-RELATED LIVER TRANSPLANTATION FOR TYPE II CITRULLINEMIA USING A GRAFT FROM HETEROZYGOTE DONOR1

  2001cited by this paper
• Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor.

  2001cited by this paper
• Long-term correction of urea cycle disorders.

  2001cited by this paper
• PRIMARY HYPEROXALURIA TYPE 1: IMPROVED OUTCOME WITH TIMELY LIVER TRANSPLANTATION: A SINGLE-CENTER REPORT OF 36 CHILDREN

  2001cited by this paper
• A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation.

  2001cited by this paper
• Urea cycle enzymes

  2001cited by this paper
• Long term results of liver-kidney transplantation in children with primary hyperoxaluria

  2001cited by this paper
• Comparison of Outcome after Pediatric Liver Transplantation for Metabolic Diseases and Biliary Atresia

  2001cited by this paper
• Liver repopulation for the treatment of metabolic diseases

  2001cited by this paper
• Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation

  2001cited by this paper
• Combined liver‐kidney and kidney‐alone transplantation in primary hyperoxaluria

  2001cited by this paper
• ORTHOTOPIC LIVER TRANSPLANTATION FOR WILSON’S DISEASE: A SINGLE-CENTER EXPERIENCE

  2001cited by this paper
• Bone mineral density in children with primary hyperoxaluria type I.

  2001cited by this paper
• The management of organic acidaemias: The role of transplantation

  2001cited by this paper
• Hereditary tyrosinaemia type I: from basics to progress in treatment

  2000cited by this paper
• Liver transplantation for alpha-1-antitrypsin deficiency in children

  2000cited by this paper
• Living-related liver transplantation for neonatal-onset propionic acidemia.

  2000cited by this paper
• Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantion

  2000cited by this paper
• Neonatal hemochromatosis: the importance of early recognition of liver failure.

  2000cited by this paper
• Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass.

  2000cited by this paper
• Long‐term results of pre‐emptive liver transplantation in primary hyperoxaluria type 1

  2000cited by this paper
• End-stage liver disease as the only consequence of a mitochondrial respiratory chain deficiency: no contra-indication for liver transplantation

  2000cited by this paper
• Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation

  2000cited by this paper
• Pre‐emptive liver transplantation in primary hyperoxaluria type 1: A controversial issue

  2000cited by this paper
• Nontransplant treatment of tyrosinemia.

  2000cited by this paper
• WILSON'S DISEASE.

  2000cited by this paper
• Alpha1-antitrypsin deficiency-associated liver disease progresses slowly in some children.

  2000cited by this paper
• LIVER INJURY IN ALPHA1-ANTITRYPSIN DEFICIENCY

  2000cited by this paper
• Liver transplantation in propionic acidaemia

  1999cited by this paper
• Liver transplantation in maple syrup urine disease

  1999cited by this paper
• Retrospective review of cystic fibrosis presenting as infantile liver disease

  1999cited by this paper
• Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure.

  1999cited by this paper
• Indications and outcome of liver transplantation in tyrosinaemia type 1

  1999cited by this paper
• Death after transplantation of a liver from a donor with unrecognized ornithine transcarbamylase deficiency.

  1999cited by this paper
• Liver transplantation for citrullinaemia improves intellectual function

  1999cited by this paper
• Liver transplantation in mitochondrial respiratory chain disorders

  1999cited by this paper
• Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia

  1999cited by this paper
• Liver transplantation for Wilson's disease: a single-center experience.

  1999cited by this paper
• Combined liver-kidney transplantation in primary hyperoxaluria type 1

  1999cited by this paper
• Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I.

  1999cited by this paper
• Liver transplantation for glycogen storage disease types I, III, and IV

  1999cited by this paper
• Mitochondria and childhood liver diseases.

  1999cited by this paper
• Oxalate Kinetics and Reversal of the Complications after Orthotopic Liver Transplantation in a Patient with Primary Hyperoxalosis Type 1 Awaiting Renal Transplantation

  1999cited by this paper
• Liver transplantation for methylmalonic acidaemia

  1999cited by this paper
• LIVER TRANSPLANTATION IN CYSTIC FIBROSIS

  1999cited by this paper
• Liver transplantation in urea cycle disorders

  1999cited by this paper
• Combined liver-kidney transplantation in methylmalonic acidemia.

  1998cited by this paper
• Liver transplantation for the treatment of urea cycle disorders

  1998cited by this paper
• Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies.

  1998cited by this paper
• Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in a living-donor program.

  1998cited by this paper
• Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.

  1998cited by this paper
• Cerebral manifestation of Wilson's disease successfully treated with liver transplantation

  1998cited by this paper
• Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes.

  1998cited by this paper
• Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation.

  1998cited by this paper
• Nontransplant alternatives for the treatment of patients with metabolic disease.

  1998cited by this paper
• The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.

  1998cited by this paper
• Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis.

  1997cited by this paper
• Focal glycogenosis of the liver in disorders of ureagenesis: Its occurrence and diagnostic significance

  1997cited by this paper
• Adult-onset type II citrullinemia: clinical pictures before and after liver transplantation.

  1997cited by this paper
• Auxiliary liver transplantation for metabolic diseases.

  1997cited by this paper
• Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature.

  1997cited by this paper
• Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.

  1997cited by this paper
• Clinical presentation of mitochondrial disorders in childhood

  1996cited by this paper
• Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats.

  1996cited by this paper
• Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I

  1996cited by this paper

• Chapter 49 – Pretransplant Evaluation and Care

  2006cites this paper